FDA-Device2023-11-08Class II
Coapt ControlSeal Electrode, cutaneous EMG Electrode
Coapt LLC
Hazard
Patient may experience minor burn or blistering if device is exposed to direct sunlight and/or warm temperatures for over 12 hours or battery is damaged.
Sold states
Worldwide distribution - US Nationwide and the countries of Australia, Canada, and Sweden.
Affected count
109 devices
Manufactured in
303 W Institute Pl Ste 200, N/A, Chicago, IL, United States
Products
Coapt ControlSeal Electrode, cutaneous EMG Electrode
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0204-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief